Review



anti cd51 61 antibody  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Santa Cruz Biotechnology anti cd51 61 antibody
    Anti Cd51 61 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 118 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd51 61 antibody/product/Santa Cruz Biotechnology
    Average 93 stars, based on 118 article reviews
    anti cd51 61 antibody - by Bioz Stars, 2026-04
    93/100 stars

    Images



    Similar Products

    93
    Santa Cruz Biotechnology anti cd51 61 antibody
    Anti Cd51 61 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd51 61 antibody/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    anti cd51 61 antibody - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology cd51 61 antibody
    Cd51 61 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd51 61 antibody/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    cd51 61 antibody - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    90
    Millipore anti-human cd51/61 antibody mab1976z
    Anti Human Cd51/61 Antibody Mab1976z, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-human cd51/61 antibody mab1976z/product/Millipore
    Average 90 stars, based on 1 article reviews
    anti-human cd51/61 antibody mab1976z - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Bio-Rad anti-cd51/61 antibody
    Anti Cd51/61 Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-cd51/61 antibody/product/Bio-Rad
    Average 90 stars, based on 1 article reviews
    anti-cd51/61 antibody - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    93
    Bio-Rad anti cd51 61 antibody
    Human osteoclasts differentiated in 3D form a more homogeneous cell population than monolayer cells. ( A – E ) Monolayer osteoclasts : ( A ) Representative images of staining for <t>CD51/61</t> (top) and visualisation of resorption tracks (bottom, scale bars = 200 µm) and ( B ) TRAP staining of osteoclasts from 4 independent donors (scale bar = 200 µm) on day 9 of differentiation showing heterogeneity of the populations; (insert) monocytes (red arrow), binuclear pre-osteoclasts (blue arrow) and mature osteoclasts (green arrow). ( C ) Rate of formation of monolayer osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( D ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( E ) Representative TRAP-stained images of the time course of osteoclast differentiation in monolayer culture (scale bar = 100 µm). ( F – H ) 3D-generated osteoclasts: Cells were fixed for analysis 4 h after reseeding onto cell culture plates ( F ) Rate of formation of 3D-generated osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( G ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( H ) Representative TRAP-stained images of the time course of osteoclast differentiation in 3D (scale bar = 100 µm). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Anti Cd51 61 Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd51 61 antibody/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    anti cd51 61 antibody - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti-cd51/61 monoclonal antibody
    Human osteoclasts differentiated in 3D form a more homogeneous cell population than monolayer cells. ( A – E ) Monolayer osteoclasts : ( A ) Representative images of staining for <t>CD51/61</t> (top) and visualisation of resorption tracks (bottom, scale bars = 200 µm) and ( B ) TRAP staining of osteoclasts from 4 independent donors (scale bar = 200 µm) on day 9 of differentiation showing heterogeneity of the populations; (insert) monocytes (red arrow), binuclear pre-osteoclasts (blue arrow) and mature osteoclasts (green arrow). ( C ) Rate of formation of monolayer osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( D ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( E ) Representative TRAP-stained images of the time course of osteoclast differentiation in monolayer culture (scale bar = 100 µm). ( F – H ) 3D-generated osteoclasts: Cells were fixed for analysis 4 h after reseeding onto cell culture plates ( F ) Rate of formation of 3D-generated osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( G ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( H ) Representative TRAP-stained images of the time course of osteoclast differentiation in 3D (scale bar = 100 µm). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Anti Cd51/61 Monoclonal Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-cd51/61 monoclonal antibody/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    anti-cd51/61 monoclonal antibody - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cd51/61 fitc 23c6 antibody
    Human osteoclasts differentiated in 3D form a more homogeneous cell population than monolayer cells. ( A – E ) Monolayer osteoclasts : ( A ) Representative images of staining for <t>CD51/61</t> (top) and visualisation of resorption tracks (bottom, scale bars = 200 µm) and ( B ) TRAP staining of osteoclasts from 4 independent donors (scale bar = 200 µm) on day 9 of differentiation showing heterogeneity of the populations; (insert) monocytes (red arrow), binuclear pre-osteoclasts (blue arrow) and mature osteoclasts (green arrow). ( C ) Rate of formation of monolayer osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( D ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( E ) Representative TRAP-stained images of the time course of osteoclast differentiation in monolayer culture (scale bar = 100 µm). ( F – H ) 3D-generated osteoclasts: Cells were fixed for analysis 4 h after reseeding onto cell culture plates ( F ) Rate of formation of 3D-generated osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( G ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( H ) Representative TRAP-stained images of the time course of osteoclast differentiation in 3D (scale bar = 100 µm). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Cd51/61 Fitc 23c6 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd51/61 fitc 23c6 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    cd51/61 fitc 23c6 antibody - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    93
    Bio-Rad murine monoclonal antibody targeting cd51 61
    Human osteoclasts differentiated in 3D form a more homogeneous cell population than monolayer cells. ( A – E ) Monolayer osteoclasts : ( A ) Representative images of staining for <t>CD51/61</t> (top) and visualisation of resorption tracks (bottom, scale bars = 200 µm) and ( B ) TRAP staining of osteoclasts from 4 independent donors (scale bar = 200 µm) on day 9 of differentiation showing heterogeneity of the populations; (insert) monocytes (red arrow), binuclear pre-osteoclasts (blue arrow) and mature osteoclasts (green arrow). ( C ) Rate of formation of monolayer osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( D ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( E ) Representative TRAP-stained images of the time course of osteoclast differentiation in monolayer culture (scale bar = 100 µm). ( F – H ) 3D-generated osteoclasts: Cells were fixed for analysis 4 h after reseeding onto cell culture plates ( F ) Rate of formation of 3D-generated osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( G ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( H ) Representative TRAP-stained images of the time course of osteoclast differentiation in 3D (scale bar = 100 µm). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Murine Monoclonal Antibody Targeting Cd51 61, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine monoclonal antibody targeting cd51 61/product/Bio-Rad
    Average 93 stars, based on 1 article reviews
    murine monoclonal antibody targeting cd51 61 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    90
    Sony primary antibody cd51/61
    Human osteoclasts differentiated in 3D form a more homogeneous cell population than monolayer cells. ( A – E ) Monolayer osteoclasts : ( A ) Representative images of staining for <t>CD51/61</t> (top) and visualisation of resorption tracks (bottom, scale bars = 200 µm) and ( B ) TRAP staining of osteoclasts from 4 independent donors (scale bar = 200 µm) on day 9 of differentiation showing heterogeneity of the populations; (insert) monocytes (red arrow), binuclear pre-osteoclasts (blue arrow) and mature osteoclasts (green arrow). ( C ) Rate of formation of monolayer osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( D ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( E ) Representative TRAP-stained images of the time course of osteoclast differentiation in monolayer culture (scale bar = 100 µm). ( F – H ) 3D-generated osteoclasts: Cells were fixed for analysis 4 h after reseeding onto cell culture plates ( F ) Rate of formation of 3D-generated osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( G ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( H ) Representative TRAP-stained images of the time course of osteoclast differentiation in 3D (scale bar = 100 µm). *, p < 0.05; **, p < 0.01; ***, p < 0.001.
    Primary Antibody Cd51/61, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody cd51/61/product/Sony
    Average 90 stars, based on 1 article reviews
    primary antibody cd51/61 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    Human osteoclasts differentiated in 3D form a more homogeneous cell population than monolayer cells. ( A – E ) Monolayer osteoclasts : ( A ) Representative images of staining for CD51/61 (top) and visualisation of resorption tracks (bottom, scale bars = 200 µm) and ( B ) TRAP staining of osteoclasts from 4 independent donors (scale bar = 200 µm) on day 9 of differentiation showing heterogeneity of the populations; (insert) monocytes (red arrow), binuclear pre-osteoclasts (blue arrow) and mature osteoclasts (green arrow). ( C ) Rate of formation of monolayer osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( D ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( E ) Representative TRAP-stained images of the time course of osteoclast differentiation in monolayer culture (scale bar = 100 µm). ( F – H ) 3D-generated osteoclasts: Cells were fixed for analysis 4 h after reseeding onto cell culture plates ( F ) Rate of formation of 3D-generated osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( G ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( H ) Representative TRAP-stained images of the time course of osteoclast differentiation in 3D (scale bar = 100 µm). *, p < 0.05; **, p < 0.01; ***, p < 0.001.

    Journal: Cells

    Article Title: A New Method to Sort Differentiating Osteoclasts into Defined Homogeneous Subgroups

    doi: 10.3390/cells11243973

    Figure Lengend Snippet: Human osteoclasts differentiated in 3D form a more homogeneous cell population than monolayer cells. ( A – E ) Monolayer osteoclasts : ( A ) Representative images of staining for CD51/61 (top) and visualisation of resorption tracks (bottom, scale bars = 200 µm) and ( B ) TRAP staining of osteoclasts from 4 independent donors (scale bar = 200 µm) on day 9 of differentiation showing heterogeneity of the populations; (insert) monocytes (red arrow), binuclear pre-osteoclasts (blue arrow) and mature osteoclasts (green arrow). ( C ) Rate of formation of monolayer osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( D ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( E ) Representative TRAP-stained images of the time course of osteoclast differentiation in monolayer culture (scale bar = 100 µm). ( F – H ) 3D-generated osteoclasts: Cells were fixed for analysis 4 h after reseeding onto cell culture plates ( F ) Rate of formation of 3D-generated osteoclasts (TRAP-positive cells with ≥3 nuclei) and ( G ) the size distribution of these osteoclasts; small (3–5 nuclei), medium (6–9 nuclei) or large (>10 nuclei). ( H ) Representative TRAP-stained images of the time course of osteoclast differentiation in 3D (scale bar = 100 µm). *, p < 0.05; **, p < 0.01; ***, p < 0.001.

    Article Snippet: CD51/61 staining: immunostaining for osteoclast-specific CD51/61 used an anti-CD51/61 antibody (clone 23C6, 1:400; BioRad, Oxford, UK) and standard DAB immunohistochemistry techniques.

    Techniques: Staining, Generated, Cell Culture

    Cell surface markers in monolayer and 3D osteoclasts. ( A ) FACS scatter graphs showing increasing cell size and complexity during differentiation from CD14+ monocytes to osteoclasts in 3D culture. ( B ) Representative data from cells from one donor showing variation in osteoclast surface markers over 24 days of differentiation. Black = monolayer cells, red = 3D-generated cells. ( C , D ) Comparison of expression of ( C ) CD9 (n = 3) and ( D ) CD51/61 (n = 5) during 3D differentiation of osteoclasts from different monocyte donors. ( E ) Double staining of 3D-generated osteoclasts on day 15 of differentiation for CD9 and CD51/61 distinguishes two osteoclast subpopulations. ( F ) Scatter graph of CD9+CD51/61−cells showing small early/pre-osteoclasts (left panel) with CD9+CD51/61+ cells being larger mature osteoclasts (right panel). ***, p < 0.001.

    Journal: Cells

    Article Title: A New Method to Sort Differentiating Osteoclasts into Defined Homogeneous Subgroups

    doi: 10.3390/cells11243973

    Figure Lengend Snippet: Cell surface markers in monolayer and 3D osteoclasts. ( A ) FACS scatter graphs showing increasing cell size and complexity during differentiation from CD14+ monocytes to osteoclasts in 3D culture. ( B ) Representative data from cells from one donor showing variation in osteoclast surface markers over 24 days of differentiation. Black = monolayer cells, red = 3D-generated cells. ( C , D ) Comparison of expression of ( C ) CD9 (n = 3) and ( D ) CD51/61 (n = 5) during 3D differentiation of osteoclasts from different monocyte donors. ( E ) Double staining of 3D-generated osteoclasts on day 15 of differentiation for CD9 and CD51/61 distinguishes two osteoclast subpopulations. ( F ) Scatter graph of CD9+CD51/61−cells showing small early/pre-osteoclasts (left panel) with CD9+CD51/61+ cells being larger mature osteoclasts (right panel). ***, p < 0.001.

    Article Snippet: CD51/61 staining: immunostaining for osteoclast-specific CD51/61 used an anti-CD51/61 antibody (clone 23C6, 1:400; BioRad, Oxford, UK) and standard DAB immunohistochemistry techniques.

    Techniques: Generated, Expressing, Double Staining

    Live cell sorting of primary human osteoclasts. ( A ) Flow cytometry of live 3D-generated human osteoclasts stained for CD51/61. ( B ) Following cell sorting, the population of CD51/61+ cells increased from 13.3% to 84.2%. ( C ) Cells re-seeded into monolayer culture after live cell sorting and analysed for the presence of osteoclasts (TRAP stain, 24 h post re-seed, scale bar = 100 µm) and resorption activity (resorption tracks on dentine, 7 days post re-seed, scale bar = 200 µm). Top panel: CD51/61-positive cells from 3D culture. Middle panel: CD51/61-negative cells from 3D culture. Bottom panel: CD51/61-positive cells from monolayer culture. ( D ) Flow cytometry of live 3D-generated human osteoclasts stained for CD9 and CD51/61. CD9+CD51/61- and CD9+CD51/61+ cells were re-seeded into monolayer culture after live cell sorting and analysed for the presence of osteoclasts 24 h post re-seed (TRAP stain, scale bar = 100 µm), quantified ( E ) as the number of nuclei per cell in these selected populations. ( F ) Area of bone resorbed by monolayer and 3D-generated osteoclasts selected for CD51/61. Black = monolayer cells, red = 3D-generated cells. ***, p < 0.001.

    Journal: Cells

    Article Title: A New Method to Sort Differentiating Osteoclasts into Defined Homogeneous Subgroups

    doi: 10.3390/cells11243973

    Figure Lengend Snippet: Live cell sorting of primary human osteoclasts. ( A ) Flow cytometry of live 3D-generated human osteoclasts stained for CD51/61. ( B ) Following cell sorting, the population of CD51/61+ cells increased from 13.3% to 84.2%. ( C ) Cells re-seeded into monolayer culture after live cell sorting and analysed for the presence of osteoclasts (TRAP stain, 24 h post re-seed, scale bar = 100 µm) and resorption activity (resorption tracks on dentine, 7 days post re-seed, scale bar = 200 µm). Top panel: CD51/61-positive cells from 3D culture. Middle panel: CD51/61-negative cells from 3D culture. Bottom panel: CD51/61-positive cells from monolayer culture. ( D ) Flow cytometry of live 3D-generated human osteoclasts stained for CD9 and CD51/61. CD9+CD51/61- and CD9+CD51/61+ cells were re-seeded into monolayer culture after live cell sorting and analysed for the presence of osteoclasts 24 h post re-seed (TRAP stain, scale bar = 100 µm), quantified ( E ) as the number of nuclei per cell in these selected populations. ( F ) Area of bone resorbed by monolayer and 3D-generated osteoclasts selected for CD51/61. Black = monolayer cells, red = 3D-generated cells. ***, p < 0.001.

    Article Snippet: CD51/61 staining: immunostaining for osteoclast-specific CD51/61 used an anti-CD51/61 antibody (clone 23C6, 1:400; BioRad, Oxford, UK) and standard DAB immunohistochemistry techniques.

    Techniques: FACS, Flow Cytometry, Generated, Staining, Activity Assay